GSK and Pfizer RSV Vaccines Nominated for 2024 Prix Galien Awards, Recognized as 'Nobel Prize of Medicine'

Aug 20, 2024 13:06 CST Updated 13:06

GSK

Pharmaceutical R&D Manufacturer

Recently, The Galien Foundation announced the list of nominees for the 2024 Prix Galien USA Awards.The Galien Award, known as the "Nobel Prize of the pharmaceutical industry," is widely regarded as the highest honor in the pharmaceutical and biomedicine sectors, recognizing outstanding scientific innovations that improve human health.

The 2024 Galien Award nominations include three categories: Best Biotechnology Product, Best Pharmaceutical Product, and Best Product for Rare/Orphan Diseases.They are all products that have been approved by the U.S. FDA for marketing within the last five years and have the potential to significantly impact human health.The judges will evaluate the products based on their scientific and health impact, without considering the sales data of the products.

Notably on this list, Pfizer has two重磅TOP10 vaccines selected, respectively.Prevnar 20and RSV bivalent vaccine Abrysvo, GSK'sArexvyAlso selected, in addition toVBI GSK's Third-Generation Hepatitis B VaccinePreHevbrio。

The 2024 Galien Award candidate list is as follows:

Best Biotechnology Product Award (Candidate Product)

Company	Product/Therapy	Introduction
Amgen and AstraZeneca	Tezspire	Targeted Anti-Thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody
Arcutis Biotherapeutics	Zoryve	Topical New-Generation Phosphodiesterase (PDE4) Inhibitor
argenx	Vyvgart	Neonatal Fc Receptor (FcRn) Blocker
AstraZeneca and Sanofi	Beyfortus	Respiratory Syncytial Virus (RSV) Antibody
BeiGene	Brukinsa	BTK Small Molecule Inhibitor
Daiichi Sankyo AstraZeneca	Enhertu	Antibody-Drug Conjugates (ADC) Targeting HER2
Genmab and AbbVie	Epkinly	Anti-CD20/CD3 Bispecific Antibody
GSK	Arexvy	RSV Vaccine
Innoviva Specialty Therapeutics	Xacduro	Antibiotic Combination Therapy
Ipsen	Bylvay	Ileal Bile Acid Transport Inhibitor
Jazz Pharmaceuticals	Rylaze	Components of Multi-Drug Chemotherapy Regimens for Hematologic Malignancies
Johnson & Johnson	Talvey	Anti-GPRC5D/CD3 Bispecific Antibody
Johnson & Johnson	Tecvayli	Bispecific Antibody Targeting BCMA
Johnson & Legend Biotech	Carvykti	CAR-T Therapy Targeting BCMA
Merck & Co.	Capvaxive	21-valent pneumococcal conjugate vaccine
MGI Tech	DNBSEQ-T20	High-throughput Sequencer
Pfizer	Prevnar 20	20-valent pneumococcal conjugate vaccine
Pfizer	Abrysvo	RSV Bivalent Vaccine
Regeneron and Sanofi	Dupixent	IL-4/IL-13 Antagonist
VBI Vaccines	PreHevbrio	Third-Generation Hepatitis B Vaccine
XVIVO Perfusion	XPS with STEEN Solution	Lung Transplant Medical Devices

Source: Table prepared by the WuXi AppTec content team

Scan the WeChat QR code to add.Medicine Space-TimeEditor

Please indicate: Name + Research Direction!